20
Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LENALIDOMIDE, with a corresponding US DMF Number 31804.
Remarkably, this DMF maintains an Active status since its submission on June 02, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 01, 2017, and payment made on June 19, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II